Cover Image
市場調查報告書

髓核置換的全球市場:醫療設備的開發平台評估

Nucleus Replacement - Medical Devices Pipeline Assessment, 2016

出版商 GlobalData 商品編碼 358893
出版日期 內容資訊 英文 45 Pages
訂單完成後即時交付
價格
Back to Top
髓核置換的全球市場:醫療設備的開發平台評估 Nucleus Replacement - Medical Devices Pipeline Assessment, 2016
出版日期: 2016年06月01日 內容資訊: 英文 45 Pages
簡介

本報告提供全球髓核置換市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再加上產品的功能·特性比較分析 (臨床實驗的進展各階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 髓核置換概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 髓核置換的企業:各臨床實驗階段的開發中產品
  • 髓核置換:各臨床實驗階段的開發中產品

第5章 髓核置換市場:企業·產品概要

  • Arthro Kinetics AG
    • 開發中產品及進行中的臨床實驗概要
  • Chi2Gel Ltd.
  • Clariance SAS
  • CryoLife, Inc.
  • Gentis Inc.
  • Hydrospine, Inc.
  • Raymedica, LLC
  • Replication Medical, Inc.
  • Spinalcyte Llc
  • Spine Wave, Inc.
  • Stryker Corporation
  • Synthes, Inc.
  • TranS1 Inc
  • Vertebral Technologies, Inc.
  • Zimmer Biomet Holdings, Inc.

第6章 髓核置換市場:目前的趨勢 (全4件)

第7章 附錄

圖表一覽

目錄
Product Code: GDME0200EPD

GlobalData's Medical Devices sector report, "Nucleus Replacement - Medical Devices Pipeline Assessment, 2016" provides an overview of Nucleus Replacement currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nucleus Replacement pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nucleus Replacement under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nucleus Replacement and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nucleus Replacement under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Nucleus Replacement Overview

3. Products under Development

  • 3.1. Nucleus Replacement - Pipeline Products by Stage of Development
  • 3.2. Nucleus Replacement - Pipeline Products by Territory
  • 3.3. Nucleus Replacement - Pipeline Products by Regulatory Path
  • 3.4. Nucleus Replacement - Pipeline Products by Estimated Approval Date
  • 3.5. Nucleus Replacement - Ongoing Clinical Trials

4. Nucleus Replacement - Pipeline Products under Development by Companies

  • 4.1. Nucleus Replacement Companies - Pipeline Products by Stage of Development
  • 4.2. Nucleus Replacement - Pipeline Products by Stage of Development

5. Nucleus Replacement Companies and Product Overview

  • 5.1. Arthro Kinetics AG Company Overview
    • 5.1.1. Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Chi2Gel Ltd. Company Overview
    • 5.2.1. Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Clariance SAS Company Overview
    • 5.3.1. Clariance SAS Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. CryoLife, Inc. Company Overview
    • 5.4.1. CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Gentis Inc. Company Overview
    • 5.5.1. Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Hydrospine, Inc. Company Overview
    • 5.6.1. Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Raymedica, LLC Company Overview
    • 5.7.1. Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Replication Medical, Inc. Company Overview
    • 5.8.1. Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Spinalcyte Llc Company Overview
    • 5.9.1. Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Spine Wave, Inc. Company Overview
    • 5.10.1. Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Stryker Corporation Company Overview
    • 5.11.1. Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Synthes, Inc. Company Overview
    • 5.12.1. Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. TranS1 Inc Company Overview
    • 5.13.1. TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Vertebral Technologies, Inc. Company Overview
    • 5.14.1. Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Zimmer Biomet Holdings, Inc. Company Overview
    • 5.15.1. Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview

6. Nucleus Replacement- Recent Developments

  • 6.1. May 04, 2016: SpinalCyte Receives New United States Patent for Spinal Disc Tissue Engineering
  • 6.2. Apr 22, 2016: SpinalCyte Receives New Canadian Patent for Spinal Disc Tissue Engineering
  • 6.3. Apr 19, 2016: SpinalCyte Announces Final Results From Phase II Animal Trials Using Human Dermal Fibroblast Transplantation for Intervertebral Disc Degeneration
  • 6.4. Mar 29, 2016: SpinalCyte Announces New Results from Phase II Animal Trials of Cell Therapy to Regenerate the Spinal Disc

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Nucleus Replacement - Pipeline Products by Stage of Development
  • Table 2: Nucleus Replacement - Pipeline Products by Territory
  • Table 3: Nucleus Replacement - Pipeline Products by Regulatory Path
  • Table 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date
  • Table 5: Nucleus Replacement - Ongoing Clinical Trials
  • Table 6: Nucleus Replacement Companies - Pipeline Products by Stage of Development
  • Table 7: Nucleus Replacement - Pipeline Products by Stage of Development
  • Table 8: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: NuReS - Product Status
  • Table 10: NuReS - Product Description
  • Table 11: Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Chi2Disc - Product Status
  • Table 13: Chi2Disc - Product Description
  • Table 14: Clariance SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: NucleoFill - Product Status
  • Table 16: NucleoFill - Product Description
  • Table 17: CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 18: Biodisc Nucleus Pulposus Replacement - Product Status
  • Table 19: Biodisc Nucleus Pulposus Replacement - Product Description
  • Table 20: Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: DiscCell - Product Status
  • Table 22: DiscCell - Product Description
  • Table 23: Gentis Inc. - Ongoing Clinical Trials Overview
  • Table 24: DiscCell - Pivotal Clinical Study Of DiscCell Augmentation Versus Microdiscectomy
  • Table 25: Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: Intervertebral Disc Repair System - Product Status
  • Table 27: Intervertebral Disc Repair System - Product Description
  • Table 28: Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: HydraFlex Nucleus Arthroplasty System - Product Status
  • Table 30: HydraFlex Nucleus Arthroplasty System - Product Description
  • Table 31: PDN-SOLO XL - Product Status
  • Table 32: PDN-SOLO XL - Product Description
  • Table 33: Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 34: NeuDisc - Product Status
  • Table 35: NeuDisc - Product Description
  • Table 36: Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 37: Spinal Disc Tissue Regenerator - Product Status
  • Table 38: Spinal Disc Tissue Regenerator - Product Description
  • Table 39: Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 40: NuCore Injectable Nucleus - Product Status
  • Table 41: NuCore Injectable Nucleus - Product Description
  • Table 42: NuCore RPXL Injectable Nucleus - Product Status
  • Table 43: NuCore RPXL Injectable Nucleus - Product Description
  • Table 44: Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 45: Aquarelle - Product Status
  • Table 46: Aquarelle - Product Description
  • Table 47: Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 48: Hydrafil - Product Status
  • Table 49: Hydrafil - Product Description
  • Table 50: TranS1 Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 51: Percutaneous Nucleus Replacement - Product Status
  • Table 52: Percutaneous Nucleus Replacement - Product Description
  • Table 53: TranS1 Inc - Ongoing Clinical Trials Overview
  • Table 54: Percutaneous Nucleus Replacement - Feasibility Study To Assess The Safety And Effectiveness Of The PNR
  • Table 55: Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: InterCushion Disc Nucleus Replacement System - Product Status
  • Table 57: InterCushion Disc Nucleus Replacement System - Product Description
  • Table 58: Vertebral Technologies, Inc. - Ongoing Clinical Trials Overview
  • Table 59: InterCushion Disc Nucleus Replacement System - A Pilot Clinical Study to Assess the Safety and Effectiveness of the InterCushion Disc Nucleus Prosthesis in Patients Receiving Discectomy
  • Table 60: Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: Newcleus - Product Status
  • Table 62: Newcleus - Product Description
  • Table 63: Regain Lumbar Artificial Disc - Product Status
  • Table 64: Regain Lumbar Artificial Disc - Product Description
  • Table 65: Glossary

List of Figures

  • Figure 1: Nucleus Replacement - Pipeline Products by Stage of Development
  • Figure 2: Nucleus Replacement - Pipeline Products by Territory
  • Figure 3: Nucleus Replacement - Pipeline Products by Regulatory Path
  • Figure 4: Nucleus Replacement - Pipeline Products by Estimated Approval Date
  • Figure 5: Nucleus Replacement - Ongoing Clinical Trials
Back to Top